concept

METABOLIC REPROGRAMMING

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about METABOLIC REPROGRAMMING: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

60Connections

17Hypotheses

1Analyses

24Outgoing

36Incoming

3Experiments

2Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	METABOLIC REPROGRAMMING
Key Genes/Proteins	APP, LRP1, MTOR, NLRP3, PINK1
Related Diseases	ATP, INFLAMMATION, MITOPHAGY, OXIDATIVE STRESS
Related Pathways	PI3K/AKT PATHWAY

Pathway Diagram

graph TD
    METABOLIC_REPROGRAMMING["METABOLIC REPROGRAMMING"]
    METABOLIC_REPROGRAMMING -->|"mediates"| Cardiac_Aging["Cardiac Aging"]
    METABOLIC_REPROGRAMMING -->|"causes"| Gemcitabine_Resistance["Gemcitabine Resistance"]
    METABOLIC_REPROGRAMMING -->|"modulates"| Cardiac_Function["Cardiac Function"]
    METABOLIC_REPROGRAMMING -->|"contributes to"| Antibacterial_Defence["Antibacterial Defence"]
    METABOLIC_REPROGRAMMING -->|"contributes to"| Endothelial_Cell_Dysfunction["Endothelial Cell Dysfunction"]
    METABOLIC_REPROGRAMMING -->|"contributes to"| Sepsis_Associated_Acute_Kidney["Sepsis-Associated Acute Kidney Injury"]
    STAT3["STAT3"] -->|"regulates"| METABOLIC_REPROGRAMMING
    INFLAMMASOME["INFLAMMASOME"] -->|"causes"| METABOLIC_REPROGRAMMING
    HIF1A["HIF1A"] -->|"mediates"| METABOLIC_REPROGRAMMING
    PI3K_AKT_HIF1A["PI3K/AKT/HIF1A"] -->|"mediates"| METABOLIC_REPROGRAMMING
    TREM2["TREM2"] -->|"regulates"| METABOLIC_REPROGRAMMING
    PI3K_Akt_HIF1__Pathway["PI3K/Akt/HIF1alpha Pathway"] -->|"mediates"| METABOLIC_REPROGRAMMING
    ubiquitin_proteasome_system["ubiquitin-proteasome system"] -->|"modulates"| METABOLIC_REPROGRAMMING

Outgoing (24)

Target	Relation	Type	Str
Stress Resilience	promotes	phenotype	0.95
Mitochondrial Biogenesis	promotes	process	0.95
Atp Production	upregulates	phenotype	0.95
Cardiac Aging	mediates	process	0.92
Cardiac Aging	modulates	process	0.90
Cellular Senescence	associated_with	process	0.90
Gemcitabine Resistance	causes	phenotype	0.90
Cancer Progression	contributes_to	phenotype	0.88
Sepsis-Associated Acute Kidney Injury	contributes_to	disease	0.85
Cardiac Function	modulates	phenotype	0.85
Cardiac Function	regulates	phenotype	0.85
Pentose Phosphate Pathway	associated_with	pathway	0.85
Antibacterial Defence	contributes_to	process	0.85
Endothelial Cell Dysfunction	contributes_to	phenotype	0.85
Pulmonary Arterial Endothelial Cell Dysfunction	contributes_to	process	0.85
Antibacterial Defense Responses	mediates	process	0.85
Cardiovascular Disease	treats	disease	0.85
Glycolysis	associated_with	pathway	0.85
Myocardial Fibrosis	involved_in	phenotype	0.82
Myocardial Hypertrophy	involved_in	phenotype	0.82
MICROGLIA	activates	cell_type	0.65
MICROGLIA	implicated_in	cell_type	0.55
FINGOLIMOD	associated_with	drug	0.45
PI3K/AKT PATHWAY	associated_with	pathway	0.45

Incoming (36)

Source	Relation	Type	Str
STAT3	regulates	protein	0.95
HIF1A	associated_with	gene	0.95
Ubiquitin-Proteasome System	involved_in	pathway	0.90
CRISPR	promotes	mechanism	0.90
Microglia	associated_with	cell_type	0.90
HIF1A	mediates	protein	0.90
PI3K/AKT/HIF1A	mediates	pathway	0.90
INFLAMMASOME	causes	protein	0.90
TREM2	regulates	protein	0.88
FDX1	regulates	protein	0.85
PI3K/Akt/HIF1α Pathway	mediates	pathway	0.85
Hypoxia	associated_with	process	0.85
ubiquitin-proteasome system	modulates	pathway	0.85
Ubiquitin-Proteasome System	regulates	pathway	0.85
PI3K/AKT/mTOR Signaling	mediates	pathway	0.85
HIF-1Α	associated_with	protein	0.85
IDH2	associated_with	gene	0.80
P53	regulates	gene	0.80
MTORC2	mediates	protein	0.80
HIF1α	mediates	protein	0.80
Epigenetic Modifications	associated_with	mechanism	0.75
GFAP-reactive astrocytes	undergoes	cell_type	0.70
lactylation	regulates	process	0.70
APP	causes	gene	0.65
MACROPHAGES	regulates	cell_type	0.65
NLRP3	regulates	gene	0.65
MTOR	regulates	gene	0.65
INFLAMMATION	regulates	phenotype	0.65
MICROGLIA	regulates	cell_type	0.65
OXIDATIVE STRESS	activates	phenotype	0.65
MACROPHAGE	regulates	cell_type	0.65
PINK1	inhibits	gene	0.65
ATP	causes	phenotype	0.65
LRP1	regulates	gene	0.65
APP	inhibits	gene	0.65
MITOPHAGY	implicated_in	phenotype	0.55

Targeting Hypotheses (17)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Metabolic Reprogramming to Reverse Senescence	1.000	-	Senescent cell clearance as neurodegener
TREM2-mTOR Co-Agonism for Metabolic Reprogramming	0.803	neurodegeneration	TREM2 agonism vs antagonism in DAM micro
SASP-Driven Microglial Metabolic Reprogramming in Synaptic P	0.796	neurodegeneration	Senolytic therapy for age-related neurod
TREM2-CSF1R Cross-Talk in Microglial Metabolic Reprogramming	0.748	neurodegeneration	Gene expression changes in aging mouse b
Disease-Associated Microglia Metabolic Reprogramming	0.718	neurodegeneration	Cell type vulnerability in Alzheimers Di

Metabolic Reprogramming via Microglial Glycolysis Inhibition	0.672	neurodegeneration	Synaptic pruning by microglia in early A
Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem	0.646	neurodegeneration	Selective vulnerability of entorhinal co
Cell-Type Specific Metabolic Reprogramming	0.643	neurodegeneration	Cell type vulnerability in Alzheimers Di
Astrocyte Metabolic Reprogramming via APOE4 Correction	0.636	neurodegeneration	Cell type vulnerability in Alzheimer's D
NRF2-Mediated Metabolic Reprogramming: HBOT as Direct NAMPT/	0.602	neurodegeneration	View
Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci	0.599	neurodegeneration	CRISPR-based therapeutic approaches for
APOE4 drives astrocyte metabolic reprogramming toward glycol	0.580	neuroscience	APOE4-driven lipid metabolism dysregulat
Oligodendrocyte Progenitor Cell Metabolic Reprogramming	0.575	neurodegeneration	Which cell types show the most significa
Digital Twin-Guided Metabolic Reprogramming	0.550	neurodegeneration	Digital biomarkers and AI-driven early d
TREM2-Mediated Microglial Metabolic Reprogramming Accelerate	0.494	neuroscience	Circuit-level neural dynamics in neurode
Metabolic Reprogramming Toward GAPDH Inhibition	0.450	neurodegeneration	How does controlled lysosomal membrane p
Mitochondrial Pyruvate Carrier Inhibition to Force Metabolic	0.350	metabolomics	Metabolomic signatures of neurodegenerat

Mentioning Analyses (1)

Scientific analyses that reference this entity

Mechanistic validation of SEA-AD differential expression hypotheses: Complement

neurodegeneration | 2026-04-10 | 0 hypotheses

Experiments (3)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Clinical outcome analysis based on IDH mutation status	clinical	gliomas	0.850	0.00	human patients	proposed	N/A
Proposed experiment from debate on Astrocytes adopt A1 (neurotoxic) an	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$100,000
Proposed experiment from debate on Microglia activate astrocytes via I	falsification	Neuroinflammation	0.400	0.50	cell_line	proposed	$80,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Saturation mutagenesis of twenty disease-associated regulatory elements at singl [PMID:31395865]	["Kircher M", "Xiong C", "Martin B", "Sc	Nature Communications	2019	267
Bergenin attenuates traumatic brain injury via inhibition of microglial PFKFB3-d [PMID:41520557]	Sun B, Zhang A, Feng S, Jamali AW, Jia Z	Int Immunopharmacol	2026	1
HK1 and HK2 Beyond Glycolysis: Mitochondrial Interactions and Dual Roles in Meta [PMID:41387352]	Pesce NA, Seminara G, Giarrusso G, Tomas	Adv Biol (Weinh)	2026	1
Glucose Metabolic Reprogramming in Microglia: Implications for Neurodegenerative [PMID:39987285]	Fang M, Zhou Y, He K, Lu Y, Tao F, Huang	Mol Neurobiol	2025	1
Deficiency of Microglial Hv1 Protects Against Lipopolysaccharide-Induced Neuroin [PMID:40911376]	Sun L, Wang X, Guan S, Zhang P, Chen D,	FASEB J	2025	1
The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer. [PMID:38904014]	Fontana F, Giannitti G, Marchesi S, Limo	Int J Biol Sci	2024	1
AST-120 alleviates renal ischemia-reperfusion injury by inhibiting HK2-mediated [PMID:39217289]	Zhou J, Zhang J, Xu F, Gao H, Wang L, Zh	Mol Med	2024	1
Hexokinase 2-mediated gene expression via histone lactylation is required for he [PMID:37463576]	Rho H, Terry AR, Chronis C, Hay N	Cell Metab	2023	1
IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresista [PMID:36637036]	Shigeta K, Hasegawa M, Hishiki T, Naito	EMBO J	2023	1
Cancer-associated mutation and beyond: The emerging biology of isocitrate dehydr [PMID:31131326]	Tommasini-Ghelfi S, Murnan K, Kouri FM,	Sci Adv	2019	1
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcino [PMID:28622513]	Cancer Genome Atlas Research Network. El	Cell	2017	1
Diagnostic, prognostic and predictive relevance of molecular markers in gliomas. [PMID:25944653]	Brandner S, von Deimling A	Neuropathol Appl Neurobiol	2015	1
IDH1 and IDH2 mutations in gliomas. [PMID:19228619]	Yan H, Parsons DW, Jin G, McLendon R, Ra	N Engl J Med	2009	1
Modulating LRP1 Pathways in Alzheimer's Disease: Mechanistic Insights and Emergi [PMID:41772271]	Mushtaq T, Hameed H, Khan MA, Tariq U, H	Molecular neurobiology	2026	0
Crosstalk Between [PMID:41899603]	["Ren Y", "Tang D", "Ding X", "He M"]	Cancers	2026	0
Resibufogenin protects against atherosclerosis in ApoE(-/-) mice through blockin [PMID:40258472]	Xiaoyang C, Yijun C, Chenguang Z, Wanyin	J Adv Res	2026	0
High- and Low-Fat Dairy Consumption and Long-Term Risk of Dementia: Evidence Fro [PMID:41406402]	Du Y, Borné Y, Samuelsson J, Glans I, Hu	Neurology	2026	0
Macrophage-Specific E3 Ubiquitin Ligase TRIM31 Reduces Atherosclerotic Plaque Fo [PMID:41410044]	Zhang J, Yu L, Yang W, Cao L, Wang X et	Circulation	2026	0
The role of astrocytes in Alzheimer's disease: Pathophysiology, biomarkers, and [PMID:41527736]	Abedin MJ, Kastanenka KV	J Alzheimers Dis	2026	0
Advancements in targeted therapies for acute myeloid leukemia. [PMID:41576755]	Connor MP, Barsouk A, Elghawy O, Lai C	Curr Opin Pharmacol	2026	0

Debates (2)

Multi-agent debates referencing this entity

Mechanistic validation of SEA-AD differential expression hypotheses: Complement

closed · Rounds: 0 · Score: 0.66 · 2026-04-21

Mechanistic validation of SEA-AD differential expression hypotheses: Complement

closed · Rounds: 0 · Score: 0.64 · 2026-04-21

Related Research

Hypotheses and analyses mentioning METABOLIC REPROGRAMMING in their description or question text

Metabolic Reprogramming via Microglial Glycolysis Inhibition

Score: 0.672 · neurodegeneration · 2026-04-02

## Mechanistic Overview Metabolic Reprogramming via Microglial Glycolysis Inhibition starts from the claim that modulati

Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancement

Score: 0.646 · neurodegeneration · 2026-04-02

## Mechanistic Overview Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancement starts from the claim that modul

Cell-Type Specific Metabolic Reprogramming

Score: 0.643 · neurodegeneration · 2026-04-13

## Mechanistic Overview Cell-Type Specific Metabolic Reprogramming starts from the claim that modulating PPARA within th

Astrocyte Metabolic Reprogramming via APOE4 Correction

Score: 0.636 · neurodegeneration · 2026-04-04

## Mechanistic Overview Astrocyte Metabolic Reprogramming via APOE4 Correction starts from the claim that modulating APO

NRF2-Mediated Metabolic Reprogramming: HBOT as Direct NAMPT/SIRT1 Activator for

Score: 0.602 · neurodegeneration · 2026-04-17

## Mechanistic Overview NRF2-Mediated Metabolic Reprogramming: HBOT as Direct NAMPT/SIRT1 Activator for Reverse Senescen

Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Circuits

Score: 0.599 · neurodegeneration · 2026-04-02

## Mechanistic Overview Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Circuits starts from the claim that mo

APOE4 drives astrocyte metabolic reprogramming toward glycolysis via PGC-1α supp

Score: 0.580 · neuroscience · 2026-04-22

**Molecular Mechanism and Rationale** The APOE4-driven metabolic reprogramming of astrocytes represents a complex casca

Oligodendrocyte Progenitor Cell Metabolic Reprogramming

Score: 0.575 · neurodegeneration · 2026-04-04

## Molecular Mechanism and Rationale Oligodendrocyte progenitor cells (OPCs) undergo a critical metabolic transformatio

Digital Twin-Guided Metabolic Reprogramming

Score: 0.550 · neurodegeneration · 2026-04-02

## Mechanistic Overview Digital Twin-Guided Metabolic Reprogramming starts from the claim that modulating PPARGC1A/PRKAA

TREM2-Mediated Microglial Metabolic Reprogramming Accelerates Tau Pathological S

Score: 0.494 · neuroscience · 2026-04-21

## Mechanistic Overview TREM2-Mediated Microglial Metabolic Reprogramming Accelerates Tau Pathological Spread starts fro

Metabolic Reprogramming Toward GAPDH Inhibition

Score: 0.450 · neurodegeneration · 2026-04-21

## Mechanistic Overview Metabolic Reprogramming Toward GAPDH Inhibition starts from the claim that modulating GAPDH, HK2

Mitochondrial Pyruvate Carrier Inhibition to Force Metabolic Reprogramming Towar

Score: 0.350 · metabolomics · 2026-04-25

Mitochondrial Pyruvate Carrier Inhibition to Force Metabolic Reprogramming Toward Ketone Utilization